Information for "Tb and viral liver disease within individuals given certolizumab pegol within AsiaPacific nations around the world and globally realworld and also clinical trial information"
From EECH Central
Basic information
Display title | Tb and viral liver disease within individuals given certolizumab pegol within AsiaPacific nations around the world and globally realworld and also clinical trial information |
Default sort key | Tb and viral liver disease within individuals given certolizumab pegol within AsiaPacific nations around the world and globally realworld and also clinical trial information |
Page length (in bytes) | 3,337 |
Page ID | 1282310 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Soncast48 (Talk | contribs) |
Date of page creation | 10:37, 20 March 2024 |
Latest editor | Soncast48 (Talk | contribs) |
Date of latest edit | 10:37, 20 March 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |